| Long name: |
VAPB Primary Polyclonal Antibody |
| Also known as: |
VAPB PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
VAPB |
| Specificity: |
This is a highly specific antibody against VAPB |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human VAPB |
| Gene ID number: |
9217 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Defects in VAPB are a cause of proximal adult autosomal dominant spinal muscular atrophy [MIM:182980], Spinal muscular atrophies are neurodegenerative disorders characterized by degeneration of lower motor neurons, The patients show a benign course, This form is a late adult onset form of the disease (after age 20 years), also called late onset spinal muscular atrophy Finkel type, leading to progressive paralysis muscular atrophy, most of them remaining ambulatory 10 to 40 years after clinical onset, VAPB contains 1 MSP domain and it may play a role in vesicle trafficking |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
ALS8, D2Abb2e, UNQ484/PRO983, VAMP B, VAMP B VAMP C, VAMP B/VAMP C, VAMP C, VAMP associated 33 kDa protein, VAMP associated protein B, VAMP associated protein B and C, VAMP associated protein B/C, VAMP associated protein C, VAMP vesicle associated membrane protein associated protein B and C, VAMPB, VAMPB/VAMPC, VAMPC, VAP 33b, VAP B, VAP B/VAP C, VAP C, VAP33b, VAPB/VAPC, VAPB_HUMAN, VAPC antibody Vesicle associated membrane protein associated protein B and C, Vamp 33b, Vamp33b, Vesicle associated membrane protein associated protein B/C, ALS 8 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
VAPB |
| Short name: |
VAPB Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
VAPB (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
12649 |
| Gene: |
VAPB |
More about : VAPB |
| Long gene name: |
VAMP associated protein B and C |
| Synonyms gene name: |
VAMP (vesicle-associated membrane protein)-associated protein B and C |
| Synonyms: |
VAP-B VAP-C ALS8 |
| Locus: |
20q13, 32 |
| Discovery year: |
1999-03-19 |
| GenBank acession: |
AF086628 |
| Entrez gene record: |
9217 |
| Pubmed identfication: |
9920726 |
| Havana BLAST/BLAT: |
OTTHUMG00000032840 |
| Locus Specific Databases: |
ALSOD, the Amyotrophic Lateral Sclerosis Online Genetic Database LRG_656 |